Stock 9969 INNOCARE PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar InnoCare Pharma Limited

Equities

9969

KYG4783B1032

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
4.45 HKD +1.37% Intraday chart for InnoCare Pharma Limited +9.61% -35.41%
Mar. 29 InnoCare Pharma Announces Dosing of First Patient in Clinical Study of the Combination of SHP2 Inhibitor ICP-189 and EGFR Inhibitor Furmonertinib CI
Mar. 28 Transcript : InnoCare Pharma Limited, 2023 Earnings Call, Mar 28, 2024

Chart calendar InnoCare Pharma Limited

851a6f34a1823ad7726eaf2bf9d.GubZ8liwaX7xvJ4uAAuur_S7TSq2ZeYd4gFctd7xoHg.UrKyxGz_Gha01Np0R2_s2ZL5A37OHJx11nZogrTB9Utz0amaKtFeDLz5zw~26d88c64cf5d68ff938eb81b1badd9ad

Upcoming events on InnoCare Pharma Limited

2024-05-06 Q1 2024 Earnings Release (Projected)
2024-06-26 Annual General Meeting
2024-08-22 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-19 Q4 2024 Earnings Release (Projected)

Past events on InnoCare Pharma Limited

2024-03-29 08:30 am Q4 2023 Earnings Release
2024-03-28 08:30 am Q4 2023 Earnings Call
2024-03-10 American Academy of Dermatology Meeting - Abstract No.: 56157
2024-01-09 08:30 am JPMorgan Healthcare Conference
2023-12-11 06:00 pm American Society of Hematology Meeting - Abstract No: 4642
2023-12-11 11:15 am American Society of Hematology Meeting - Abstract No.: 736
2023-12-10 06:00 pm American Society of Hematology Meeting - Abstract No.: 3039
2023-11-12 Q3 2023 Earnings Release
2023-08-30 10:00 pm Extraordinary Shareholders Meeting
2023-08-30 08:00 am Q2 2023 Earnings Call
2023-08-28 Q2 2023 Earnings Release
2023-06-15 Malignant Lymphoma International Conference - Abstract Number: Nr.283
2023-06-07 European Hematology Association Hybrid Congress - Abstract Number: P1165
2023-06-07 European Hematology Association Hybrid Congress - Abstract Number: P1196
2023-06-07 European Hematology Association Hybrid Congress - Abstract Number: S299
2023-06-02 03:00 am Annual General Meeting
2023-05-08 Q1 2023 Earnings Release
2023-03-28 08:00 am Q4 2022 Earnings Call
2023-03-27 Q4 2022 Earnings Release
2023-01-20 12:00 pm American Society of Clinical Oncology Gastrointestinal Cancers Symposium - Abstract Number: 572

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CNY		Released
Forecast
Spread 		1,25


1,36
4,45
-69.34%		1 043
1 013
2.99%		625
608
2.83%		739
720
2.54%
849

EBITDA
Million CNY		Released
Forecast
Spread 		0,00


-548
-498
-9.88%		-150
-39,2
-282.94%		-716
-743
3.63%		0,00
-633
-
-657

EBIT
Million CNY		Released
Forecast
Spread 		0,00


-559
-504
-10.82%		-182
-280
34.92%		-777
-814
4.57%		-701
-752
6.75%
-766

Earnings before Tax (EBT)
Million CNY		Released
Forecast
Spread 		0,00


-464
-481
3.45%		-20,1
110
-118.24%		-894
-838
-6.62%		-644
-796
19.08%
-685

Net income
Million CNY		Released
Forecast
Spread 		0,00


-464
-477
2.78%		-64,5
73,7
-187.59%		-887
-827
-7.26%		-631
-755
16.4%
-675

EPS
CNY		Released
Forecast
Spread 		-9,32


-0,48
-0,53
9.13%		-0,05
0,05
-198.33%		-0,60
-0,51
-16.61%		-0,37
-0,46
19.77%
-0,41

Announcement Date18/03/2026/03/2122/03/2227/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 S1 2025 S2
Net sales
Million CNY		Released
Forecast
Spread 		0,75
0,62
19.87%		0,62
0,50
23.45%		102
91,1
11.53%		941
915
2.87%		246
230
6.84%		196
159
23.24%		184
205
-10.16%		379
400
-5.19%


160


201
176
14.08%		361
336
7.33%
182


202


384


208


225


433


486


730

EBIT
Million CNY		Released
Forecast
Spread





-212





-355
-427
16.81%		-398
-306
-30.06%		-233
-183
-26.91%		-380
-377
-0.8%






-359

-366
-536
31.66%























EPS
CNY		Released
Forecast
Spread





-0,16
-0,18
11.11%		0,11
0,39
-71.79%		-0,31
-0,26
-19.23%





-0,29
-0,31
4.92%		-0,25
-0,20
-25%		-0,06





-0,12


























Announcement Date21/08/2026/03/2127/08/2122/03/2221/08/2213/11/2227/03/2327/03/2329/08/2313/11/2328/03/2428/03/24--------

Upcoming sector events for InnoCare Pharma Limited

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for InnoCare Pharma Limited

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 9969 Stock
  4. Calendar InnoCare Pharma Limited